Interoperability, Innovation, and Expansion: Policy Dynamics in Healthcare Technology
Policy Analysis and Impact on TeleTracking
Operational health technology platforms operate at the crossroads of hospital operations, public health infrastructure, and digital health transformation. As such, these companies are uniquely impacted by a wide range of health policy frameworks that span federal mandates, state regulations, and evolving compliance standards in health information technology. Key among these policies are the 21st Century Cures Act, CMS interoperability regulations, HIPAA, and competition law enforcement within the health IT market. Together, these policies shape not only the systems these platforms build but also the ways in which they interact with clients, integrate with existing infrastructure, and contribute to broader policy goals such as health equity, data accessibility, and operational efficiency.
Interoperability and the 21st Century Cures Act
The most important policy framework currently influencing digital health is the 21st Century Cures Act, signed into law in 2016. A major provision of this law targets information blocking and mandates widespread interoperability in electronic health information systems. The Office of the National Coordinator for Health Information Technology (ONC) further operationalized this law through the Cures Act Final Rule, which came into effect in 2021. This rule requires that certified health IT developers, healthcare providers, and networks make patient data accessible in a secure and standardized format, specifically through open APIs using Fast Healthcare Interoperability Resources (FHIR).
For operational health technology vendors that build platforms supporting hospital command centers, patient throughput, and bed management, these rules mean that the systems they design must integrate seamlessly with existing electronic health record (EHR) platforms without obstructing data flow. Moreover, the systems must be built in a way that supports patients’ rights to access their own health information. Although these vendors are not EHR providers, their tools sit adjacent to EHR systems, often exchanging operational and clinical data in near real-time. Therefore, interoperability is not a peripheral feature but a core requirement. Compliance with these mandates is necessary for product viability, especially as health systems grow increasingly wary of vendor lock-in and noncompliant platforms.
CMS Interoperability and Patient Access Rules
The Centers for Medicare and Medicaid Services (CMS) introduced complementary rules that extend the goals of the Cures Act to payers and healthcare delivery organizations. The CMS Interoperability and Patient Access Final Rule, released in 2020, mandates that Medicare Advantage, Medicaid, and CHIP managed care plans provide patients with digital access to their records through FHIR-based APIs. These rules also require payer-to-payer data exchange and support for provider directories to enhance care coordination.
Although CMS policies are more directly applicable to insurers and clinical providers, they have downstream implications for operational health technology vendors. Hospitals must ensure that their technology stack enables the data flows required under these rules. If a hospital is unable to exchange the necessary data due to infrastructure limitations, they may face regulatory consequences or be disqualified from participating in certain CMS programs. These platforms must therefore support these objectives, even if indirectly, by ensuring that patient and operational data can be exported, integrated, and reported in compliance with CMS standards.
Health IT Competition and Antitrust Oversight
A growing area of policy concern is the consolidation of the health IT market, particularly within the EHR sector. Vendors such as Epic and Oracle Cerner hold significant market share, and their platforms often create high switching costs or impose technical limitations on third-party integrations. These practices can stifle innovation and restrict patient access to their own data. In response, the Federal Trade Commission (FTC) and Department of Justice (DOJ) have increased scrutiny of health IT mergers and contractual practices that limit data interoperability.
This trend may benefit operational health technology vendors. Unlike traditional EHR companies, these firms often offer operational and logistical tools that complement clinical records rather than replace them. Their neutral position in the EHR ecosystem may become more attractive to health systems that are under pressure to avoid vendor lock-in and to diversify their health IT partnerships. Regulatory support for increased competition could enable these vendors to expand their footprint within hospitals and position themselves as compliance-friendly alternatives to larger, more restrictive platforms.
HIPAA and Privacy Compliance
While policies such as the Cures Act push for open data exchange, the Health Insurance Portability and Accountability Act (HIPAA) continues to define the boundaries of privacy and security in healthcare. HIPAA requires that all entities handling protected health information implement appropriate safeguards to ensure data confidentiality, integrity, and availability. For companies working with hospitals, any tool that stores, transmits, or processes health data must be HIPAA compliant.
Operational health technology systems often deal with sensitive data, such as patient admissions, transfers, and discharges. Even when this data is not tied directly to a diagnosis or clinical procedure, it may still qualify as protected health information under HIPAA. Compliance must therefore be built into the architecture of all tools. Role-based access, audit trails, encryption protocols, and secure hosting environments are all essential components. As vendors expand into more advanced uses of predictive analytics or artificial intelligence, additional attention will need to be paid to how these technologies intersect with evolving privacy standards.
Artificial Intelligence and Emerging Governance
Many operational health technology vendors are beginning to incorporate artificial intelligence into hospital operations. While AI in healthcare is still lightly regulated in the United States, federal agencies are beginning to release guidance. The Food and Drug Administration (FDA), for example, has proposed a framework for regulating software as a medical device, which could potentially cover AI tools that influence clinical or operational decisions. The National Institute of Standards and Technology (NIST) and the ONC have also released guidance around algorithm transparency, fairness, and reproducibility.
For vendors in this space, this is a rapidly evolving area. AI tools used to optimize staffing, predict bed availability, or anticipate patient surges must be explainable and evidence-based. Hospitals will likely demand regulatory clarity and documentation showing that algorithms do not reinforce bias, breach patient privacy, or cause operational harm. As AI becomes more central to these platforms’ value propositions, staying ahead of federal and state-level guidance will be critical.
Reflections and Strategic Perspective
Based on this analysis, the current regulatory environment provides operational health technology vendors with a unique opportunity to grow, provided that they continue to align their products with federal priorities around interoperability, equity, and data transparency. While some may view compliance obligations as burdensome, they can also serve as strategic differentiators. Companies that are agile, standards-compliant, and open to integration are increasingly preferred by hospitals navigating complex vendor landscapes.
A recent article in Health Affairs supports this view. The authors argue that interoperability mandates have not only improved patient data access but also catalyzed a shift in how health systems evaluate their IT vendors (Adler-Milstein et al., 2022). Health systems are moving away from all-in-one solutions and are instead creating modular environments where best-in-class tools can coexist. In such an environment, vendors that specialize in operational visibility and logistical command centers can provide distinct value without having to compete directly with EHR giants.
There is also strong evidence that hospitals are increasingly prioritizing operational efficiency and system-wide coordination in response to capacity pressures. A study published in The New England Journal of Medicine Catalyst found that patient flow optimization can improve not only bed utilization but also staff morale and patient outcomes (Haas et al., 2021). Operational health technology platforms are well positioned in this space. Their tools address real logistical bottlenecks in hospital settings, and the broader policy environment now actively encourages the use of data-driven solutions.
At the same time, vendors will need to pay close attention to emerging debates around the ethical use of AI in hospital operations. While these platforms may not make clinical decisions directly, their algorithms may influence how resources are allocated, how patients are prioritized, and how staff are deployed. These are sensitive areas. As AI oversight evolves, there may be calls for greater algorithm transparency and accountability, even outside of traditional clinical use. Hospitals are becoming more aware of these issues, especially after high-profile incidents involving biased algorithms in care delivery models (Obermeyer et al., 2019). Vendors should be proactive in disclosing how their models are built, validated, and monitored to ensure they do not unintentionally exacerbate inequities.
Finally, continued investment in comparative policy research will be important. Health systems globally are experimenting with different ways of governing digital health, and U.S. regulators often look abroad when crafting new frameworks. Staying informed about how other countries are regulating data sharing, digital infrastructure, and AI could help vendors anticipate changes at home.
International Policy and Emerging Considerations
Operational health technology vendors increasingly operate across multiple countries, including the United States, the United Kingdom, Canada, and Germany. Each of these markets presents unique regulatory landscapes that influence how health technologies are developed, certified, and integrated into public systems. In each jurisdiction, policies governing data exchange, privacy, reimbursement, and digital infrastructure pose both opportunities and challenges for expansion.
United Kingdom
The United Kingdom offers a particularly interesting environment for operational health technologies. The National Health Service (NHS), as a publicly funded and centrally coordinated healthcare system, has made clear commitments to digital transformation. In recent years, the NHS has piloted and expanded the use of real-time hospital command centers to manage patient flow, reduce waiting times, and coordinate emergency response.
UK digital health policy is primarily shaped by NHS England and the Department of Health and Social Care. NHS Digital (now merged into NHS England) previously released blueprints for digital maturity and interoperability that emphasize open APIs, structured data exchange, and real-time dashboards. These align closely with the operational tools these vendors provide. For example, the NHS Data Services Platform and Federated Data Platform initiatives create the infrastructure for shared visibility across hospitals and care settings, capabilities that operational command platforms are well designed to support.
However, the United Kingdom also poses significant regulatory expectations. The UK General Data Protection Regulation (UK GDPR), which mirrors the EU GDPR in many respects, sets high standards for data protection, consent, and transparency. Systems must be carefully configured to meet these expectations, especially when handling sensitive operational data linked to patient care pathways. In addition, the NHS often acts as both the funder and the regulator, meaning that digital tools must pass rigorous assessments on usability, safety, and cost-effectiveness before being adopted at scale.
Expanding further in the UK may require deeper engagement with national frameworks such as the NHS Innovation Service, which helps health technology developers navigate regulatory approvals. Demonstrating a strong commitment to transparency, patient safety, and public value will be essential in gaining trust within the highly centralized and policy-driven NHS environment.
Canada
Canada’s healthcare system is decentralized, with health technology procurement and policy decisions largely made at the provincial level. Each province operates under its own legislation governing health data privacy and system integration. For example, Ontario enforces the Personal Health Information Protection Act (PHIPA), while Alberta follows the Health Information Act. These laws are similar in scope to HIPAA but often emphasize the public stewardship of health data.
Despite provincial fragmentation, there is a national movement toward more coordinated digital infrastructure, led by Canada Health Infoway. Infoway’s goals include promoting interoperability, e-referrals, and real-time access to hospital resource data, all of which align well with operational health technology platforms. In addition, Canada has invested in digital tools to address hospital overcrowding, delayed discharges, and long emergency department wait times.
The main challenge for expansion in Canada lies in the need to tailor compliance and integration strategies to each province. Vendor approval processes, procurement requirements, and IT architecture standards may vary significantly across regions. However, once established, partnerships with regional health authorities or hospital networks can provide a reliable and scalable path forward.
Germany
Germany’s regulatory approach to digital health is grounded in a legal and technical structure that combines innovation support with strict oversight. The country’s Digital Healthcare Act (Digitale-Versorgung-Gesetz), passed in 2019, created a formal reimbursement pathway for digital health applications. However, much of this support has focused on patient-facing tools rather than hospital operations. For operational health technology vendors, entering the German market means navigating both data protection under the European Union’s General Data Protection Regulation (GDPR) and health IT certification requirements set by national authorities.
Data privacy in Germany is particularly strict. Any platform that collects or processes health-related data must undergo thorough data protection impact assessments and ensure full GDPR compliance. Hosting data locally within the European Union is often required. Integration with Germany’s telematics infrastructure and electronic patient record (ePA) systems may also be necessary, depending on the scope of services provided.
Despite these regulatory complexities, Germany represents a valuable opportunity. The country’s hospitals are actively seeking operational solutions to improve efficiency and adapt to changing demographics. Strengths in bed management, staff coordination, and discharge planning could serve these needs well if adapted to German specifications. Strategic partnerships with health insurers, public hospital consortia, or medical universities could provide a pathway into the market while meeting local regulatory expectations.
Other Emerging and Cross-Border Policies
Beyond these three countries, broader policy developments across jurisdictions may influence how operational health technology vendors expand or adapt their product offerings. Notable among these are the following:
In the United States, emerging rules around artificial intelligence oversight, particularly from the FDA and ONC, may begin to define expectations for algorithm transparency and validation in non-clinical systems.
The European Commission’s proposed Artificial Intelligence Act, while not yet finalized, is expected to introduce risk classifications and oversight requirements for health-related algorithms. If enacted, this would apply to any vendor offering AI-driven hospital operations tools in EU countries.
Ongoing debates around hospital price transparency, public reporting of operational metrics, and CMS value-based care reforms may create both challenges and opportunities for analytics platforms that measure or display hospital performance.
In Australia, recent updates to the National Digital Health Strategy and the expansion of the My Health Record platform indicate a growing market for tools that support system-level coordination, which may make it a future candidate for TeleTracking expansion.
Policymakers in Hong Kong and Singapore are also advancing hospital integration strategies through smart hospital initiatives and real-time dashboards, presenting another area for potential research and engagement.
Staying ahead of these developments will require continuous monitoring of legislative agendas, public consultations, and regulatory agency activity. In addition, participating in working groups, public health coalitions, or standards bodies may help vendors not only adapt to policy but also contribute to shaping it.
*Note: This brief was originally developed as a case-based analysis of an operational health technology platform. The version presented here has been generalized to focus on sector-wide policy dynamics while preserving the underlying regulatory analysis.